PGPCX
Price
$26.52
Change
+$0.01 (+0.04%)
Updated
Jul 18 closing price
Net Assets
2.2B
RLBBX
Price
$36.55
Change
-$0.03 (-0.08%)
Updated
Jul 18 closing price
Net Assets
252.37B
Interact to see
Advertisement

PGPCX vs RLBBX

Header iconPGPCX vs RLBBX Comparison
Open Charts PGPCX vs RLBBXBanner chart's image
George Putnam Balanced C
Price$26.52
Change+$0.01 (+0.04%)
VolumeN/A
Net Assets2.2B
American Funds American Balanced R2
Price$36.55
Change-$0.03 (-0.08%)
VolumeN/A
Net Assets252.37B
PGPCX vs RLBBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGPCX vs. RLBBX commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGPCX is a Buy and RLBBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 252B vs. PGPCX (2.2B). RLBBX pays higher dividends than PGPCX: RLBBX (1.17) vs PGPCX (1.01). PGPCX was incepted earlier than RLBBX: PGPCX (26 years) vs RLBBX (23 years). PGPCX (1.68) is less costly to investors than RLBBX (1.32). PGPCX is a more actively managed with annual turnover of: 80.00 vs. RLBBX (44.00). PGPCX has a lower initial minimum investment than RLBBX: PGPCX (0) vs RLBBX (250). RLBBX annual gain was more profitable for investors over the last year : 6.25 vs. PGPCX (5.63). RLBBX return over 5 years is better than : 34.69 vs. PGPCX (26.90).
PGPCXRLBBXPGPCX / RLBBX
Total Expense Ratio1.681.32127%
Annual Report Gross Expense Ratio1.681.32127%
Fund Existence26 years23 years-
Gain YTD5.2177.70368%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.2B252B1%
Annual Yield % from dividends1.011.1786%
Returns for 1 year5.636.2590%
Returns for 3 years37.5933.45112%
Returns for 5 years26.9034.6978%
Returns for 10 years62.9255.41114%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHV2.750.06
+2.23%
Achieve Life Sciences
LIXT3.780.06
+1.61%
Lixte Biotechnology Holdings
DORM122.401.08
+0.89%
Dorman Products
ALNT39.47N/A
N/A
Allient
SMMT27.63-0.64
-2.26%
Summit Therapeutics